Podiatrists in Elko, NV Accepting Medicare

6 Podiatrists found. Showing 1 - 6

Draper & Patton Ltd. Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1775 Browning Way Ste 101, Elko, NV 89801 Phone: 775-753-4044    Fax: 775-753-5694

John Patton Ltd Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 1775 Browning Way, Suite 101, Elko, NV 89801 Phone: 775-753-4044    Fax: 775-753-5694

Draper And Patton, Ltd Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1775 Browning Way Ste 101, Elko, NV 89801 Phone: 775-753-4044

Shane Draper Ltd Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 1995 Errecart Blvd, Suite #200, Elko, NV 89801 Phone: 775-738-1100    Fax: 775-738-1101

Dr. John Patrick Patton, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1775 Browning Way, Suite 101, Elko, NV 89801 Phone: 775-753-4044    Fax: 775-753-5694

Shane D. Draper, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1995 Errecart Blvd, #200, Elko, NV 89801 Phone: 775-738-1100    Fax: 775-738-1101

News Archive

Energy drinks can have adverse health effects on youth, study reveals

Over half of Canadian youth and young adults who have consumed energy drinks have experienced negative health effects as a result, according to a study from the University of Waterloo.

Curis and Debiopharm present data for Debio 0932 at Annual Meeting of AACR

Curis, Inc., an oncology focused company developing novel, targeted drug candidates for the treatment of human cancers, and Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology as well as companion diagnostics, today announced presentation of data for Debio 0932 at the Annual Meeting of the American Association for Cancer Research (AACR) that demonstrated synergy between Debio 0932 and various standard of care (SOC) agents in multiple in vitro and xenograft models of non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC).

BioTrends Research Group's syndicated reports provide comprehensive insight on renal anemia market

BioTrends Research Group, Inc. is pleased to announce the availability of its TreatmentTrends®: US Nephrology, EU Nephrology, and Canadian Nephrology publications. The reports are based on responses to online surveys completed by over 300 Nephrologists in the US, over 200 Nephrologists in Europe (UK, France, Germany, Italy and Spain) and 40 Nephrologists in Canada during November / December 2009.

PD-L1 protein could be a potential immunotherapy target for malignant pleural mesothelioma

Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to data from a prospective randomized phase II trial presented at ESMO 2014 Congress in Madrid.

HHS says marketplace customers can automatically renew their plans

The announcement says people getting subsidies will be allowed to renew for 2015 without filing an application or going back on healthcare.gov. But consumer advocates caution that may not be the best option for those customers.

Read more Medical News

› Verified 6 days ago